- Home
- ARWR vs IHS Comparison
ARWR vs IHS Comparison
Compare ARWR & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- IHS
- Stock Information
- Founded
- ARWR 2003
- IHS 2001
- Country
- ARWR United States
- IHS United Kingdom
- Employees
- ARWR N/A
- IHS N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- IHS Telecommunications Equipment
- Sector
- ARWR Health Care
- IHS Telecommunications
- Exchange
- ARWR Nasdaq
- IHS Nasdaq
- Market Cap
- ARWR 1.8B
- IHS 1.6B
- IPO Year
- ARWR 1993
- IHS 2021
- Fundamental
- Price
- ARWR $13.03
- IHS $5.70
- Analyst Decision
- ARWR Buy
- IHS Strong Buy
- Analyst Count
- ARWR 11
- IHS 5
- Target Price
- ARWR $41.44
- IHS $7.60
- AVG Volume (30 Days)
- ARWR 1.6M
- IHS 883.8K
- Earning Date
- ARWR 05-12-2025
- IHS 05-16-2025
- Dividend Yield
- ARWR N/A
- IHS N/A
- EPS Growth
- ARWR N/A
- IHS N/A
- EPS
- ARWR N/A
- IHS N/A
- Revenue
- ARWR $2,500,000.00
- IHS $1,711,225,000.00
- Revenue This Year
- ARWR $4,380.43
- IHS $0.51
- Revenue Next Year
- ARWR $64.24
- IHS $6.34
- P/E Ratio
- ARWR N/A
- IHS N/A
- Revenue Growth
- ARWR N/A
- IHS N/A
- 52 Week Low
- ARWR $9.57
- IHS $2.44
- 52 Week High
- ARWR $30.41
- IHS $5.75
- Technical
- Relative Strength Index (RSI)
- ARWR 47.38
- IHS 67.44
- Support Level
- ARWR $12.44
- IHS $4.85
- Resistance Level
- ARWR $14.97
- IHS $6.00
- Average True Range (ATR)
- ARWR 0.74
- IHS 0.25
- MACD
- ARWR 0.11
- IHS 0.08
- Stochastic Oscillator
- ARWR 37.01
- IHS 77.36
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.